Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T13:09:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a terminology transition. It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-24T13:37:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:31:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:41:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a clear 403 Forbidden message to the error page, a Home button for navigation, and a revision banner. This conveys access restrictions and provides a quick way back to the homepage.
    Difference
    19%
    Check dated 2026-09-19T19:08:59.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a frontend deployment; no substantive study details are reflected in the visible content.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:57.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.